malondialdehyde has been researched along with aclarubicin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hong, YS; Kim, TY; Lee, HS; Lee, JJ; Ryu, JS; Sohn, UD | 1 |
1 other study(ies) available for malondialdehyde and aclarubicin
Article | Year |
---|---|
In vivo antitumor efficacy and cardiotoxicity of novel anthracycline ID6105 (11-hydroxy-aclacinomycin X, Hyrubicin).
Topics: Aclarubicin; Animals; Antineoplastic Agents; Cell Line, Tumor; Doxorubicin; Female; Heart; Humans; Male; Malondialdehyde; Mice; Mice, Inbred BALB C; Myocardium; Nucleic Acid Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Topoisomerase II Inhibitors; Tumor Burden; Xenograft Model Antitumor Assays | 2006 |